Hailing Liu

Circ_0092012 knockdown restrains non-small cell lung cancer progression by inhibiting cell malignant phenotype and immune escape through microRNA-635/programmed death ligand 1 axis

Jian Zhu, Xiao-Li Zhu, Guoping Chen, 2022, Bioengineered.

Integrated driver mutations profile of chinese gastrointestinal-natural killer/T-cell lymphoma

Yan Huang, Hongfeng Yu, Ming Li, 2022, Frontiers in Oncology.

CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant Melanoma

Shirley X. Liu, G. Boland, A. Sahu, 2020, Genom. Proteom. Bioinform..

CRISPR Screens Identify Essential Cell Growth Mediators in BRAF-inhibitor Resistant Melanoma

Myles Brown, Nicole Traugh, Sailing Shi, 2019, bioRxiv.

CRISPR/Cas9 screens Reveal Dasatinib Targets of Inhibiting T cell Activation and Proliferation

Wei Li, T. Xiao, Binbin Wang, 2018, bioRxiv.

Long-term Complete Remission of Decitabine-Primed Tandem CD19/CD22 CAR-T Therapy with PD-1 and BTK Inhibitors Maintenance in a Refractory PCNSL Patient.

Xiaoping Zhou, Depei Wu, F. Xia, 2023, Cancer research and treatment.